The sales of nuclear imaging equipment are estimated to evolve at a CAGR of 5.4% between 2024 and 2034. The nuclear imaging equipment market size is expected to expand from US$ 3 billion in 2024 to US$ 5.1 billion through 2034.
Due to applied research and technological improvements, the nuclear imaging device market has been expanding steadily. The aging population's heart and neurological conditions, as well as the rising rate of cancer, are contributing factors to the nuclear imaging equipment market’s upward trend.
The nuclear imaging equipment industry is growing faster due to better healthcare facilities, more diagnostic imaging centers, better health insurance, and more advantageous reimbursement practices in emerging economies.
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 3 billion |
| Market Value for 2034 | US$ 5.1 billion |
| Market CAGR from 2024 to 2034 | 5.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Attributes | Details |
|---|---|
| Market Value for 2019 | US$ 2.1 billion |
| Market Value for 2023 | US$ 2.8 billion |
| Market CAGR from 2019 to 2023 | 7.1% |
Principal Consultant
The nuclear medicine equipment market and the molecular imaging market have both been studied by Future Market Insights (FMI). The data depict the projected growth of the nuclear imaging system market from 2024 to 2034 with regard to other markets. It showcases the potential for revenue in the additional markets shown below.
Nuclear Imaging Equipment Market:
| Attributes | Nuclear Imaging Device Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 5.4% |
| Growth Factor | Global aging populations are increasing the demand for diagnostic imaging, stimulating nuclear imaging equipment market growth. |
| Market Trend | Rising investments in healthcare infrastructure in emerging economies facilitate nuclear imaging instrument market expansion. |
| Market Restraint | Reimbursement issues and limited coverage for nuclear imaging treatments hinder the market growth of nuclear imaging equipment. |
Nuclear Medicine Equipment Market:
| Attributes | Nuclear Medicine Equipment Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 4.1% |
| Growth Factor | Globally growing older populations require increasingly advanced diagnostic technologies, fueling demand for nuclear medicine equipment. |
| Market Trend | Nuclear medicine technology adoption is attributed to a growing understanding of early disease identification and customized therapy choices. |
| Market Restraint | Expanding the nuclear medicine equipment market is thwarted by a shortage of qualified personnel adept at using nuclear medical equipment. |
Molecular Imaging Market:
| Attributes | Molecular Imaging Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 11.0% |
| Growth Factor | The molecular imaging market expansion is supported by government programs that encourage the development of healthcare infrastructure and financing for research. |
| Market Trend | A growing understanding of the advantages of early disease detection and therapy monitoring propels the adoption of molecular imaging technologies. |
| Market Restraint | Economic downturns and budgetary restraints in healthcare spending adversely affect molecular imaging technology investment. |
In the segmented nuclear imaging equipment market analysis, SPECT systems emerge as the prevalent product category endowed by expansive research. Within applications, oncology leads the way, supported by comprehensive studies.
These discoveries underscore the significance of SPECT systems in diagnosing various conditions, particularly in oncology, reflecting a trend toward precision medicine and targeted therapies.
| Attributes | Details |
|---|---|
| Top Product | SPECT Systems |
| CAGR % 2019 to 2023 | 6.9% |
| CAGR % 2024 to End of Forecast (2034) | 5.1% |
| Attributes | Details |
|---|---|
| Top Application | Oncology |
| CAGR % 2019 to 2023 | 6.6% |
| CAGR % 2024 to End of Forecast (2034) | 4.8% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Tables highlighting South Korea, Japan, China, the United States, and the United Kingdom illustrate the market's considerable potential for nuclear imaging equipment. Based on a comprehensive analysis, South Korea is considered especially promising, offering significant growth potential in the global nuclear imaging equipment market.
| Country | South Korea |
|---|---|
| HCAGR (2019 to 2023) | 11.4% |
| CAGR (2024 to 2034) | 7.2% |
| Country | Japan |
|---|---|
| HCAGR (2019 to 2023) | 9.4% |
| CAGR (2024 to 2034) | 6.5% |
| Country | China |
|---|---|
| HCAGR (2019 to 2023) | 8.8% |
| CAGR (2024 to 2034) | 6.3% |
| Country | United States |
|---|---|
| HCAGR (2019 to 2023) | 7.8% |
| CAGR (2024 to 2034) | 5.7% |
| Country | United Kingdom |
|---|---|
| HCAGR (2019 to 2023) | 5.3% |
| CAGR (2024 to 2034) | 4.3% |
A few nuclear imaging equipment manufacturers control a large portion of the market, which fosters innovation and shapes the sector. Leading the way are reputable companies with a track record of innovation, such as Siemens Healthineers, GE Healthcare, and Koninklijke Philips N.V. The nuclear imaging equipment vendors push the envelope and establish standards for nuclear imaging technology improvements.
Other prominent nuclear imaging equipment providers, like Toshiba Corporation and Hitachi Ltd., enhance the competitive landscape with various products and services by bringing their knowledge and contributions. These producers use their advantages in manufacturing, research and development, and research to stay ahead of the nuclear imaging equipment market.
Emerging nuclear imaging equipment producers, such as Canon Medical Systems Corporation and Neusoft Medical Systems Co., Ltd., challenge conventional wisdom and spur competitiveness by bringing new ideas and inventiveness. The nuclear imaging tool market is partly dynamic because of its adaptability and commitment to meeting changing client needs.
The market's competitive dynamics are shaped by regional nuclear imaging equipment suppliers and niche specialists that provide specialized services to target market segments and geographic areas. The demand is defined by fierce competition among major nuclear imaging equipment manufacturers fueled by innovation, dependability, and a never-ending quest for excellence, guaranteeing ongoing breakthroughs and better patient outcomes.
Notable Developments
| Company | Details |
|---|---|
| Koninklijke Philips N.V. | Mercurius Health, Elekta, and Koninklijke Philips N.V. announced in May 2023 a three-year contract under which Mercurius Health is going to set up informatics solutions and diagnostic and therapeutic oncology equipment from Elekta at the recently acquired Robert Janker Klinik cancer center in Bonn, Germany. |
| Bartec Technologies Ltd. | The United Kingdom-based business Bartec Technologies Ltd., which specializes in providing, installing, and maintaining accessories and equipment for nuclear medicine and molecular imaging, was acquired by Mediso Ltd. in April 2022. It is anticipated that this acquisition will enhance Mediso's standing in the marketplaces in the UK and Ireland. |
| Siemens Healthineers | Siemens Healthineers unveiled the Symbia Pro. specta, a SPECT/CT system that the FDA and CE have approved marked, in June 2022. Advanced SPECT and CT imaging technologies are included in this system. Among the noteworthy characteristics is a low-dose CT that can record up to 64 slices and provide detailed imaging. |
| Canon, Inc. | Canon, Inc. decided to create a brand-new company in November 2022, naming it Canon Healthcare the United States of America INC. By strengthening its position in the United States medical market, Canon contributed to the growth of the medical industry. |
The nuclear imaging device market to secure a valuation of US$ 3 billion in 2024.
The nuclear imaging instrument market is estimated to reach US$ 5.1 billion by 2034.
Through 2034, the nuclear imaging system market is anticipated to expand at a 5.4% CAGR.
From 2019 to 2023, the nuclear imaging tool market recorded a 7.1% HCAGR.
The SPECT systems sector is set to accelerate at a CAGR of 5.1% from 2024 to 2034.
The oncology sector is predicted to thrive at a CAGR of 4.8% through 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034 5.3.1. SPECT Systems 5.3.2. Hybrid PET Systems 5.3.3. Planar Scintigraphy 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034 6.3.1. Oncology 6.3.2. Cardiology 6.3.3. Neurology 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2024 to 2034 7.3.1. Hospitals 7.3.2. Imaging Centers 7.3.3. Academic and Research Centers 7.3.4. Others 7.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End-User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End-User 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End-User 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End-User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Application 12.2.4. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End-User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Application 13.2.4. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End-User 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Application 14.2.4. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By End-User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Application 15.2.4. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By End-User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product 16.1.2.2. By Application 16.1.2.3. By End-User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product 16.2.2.2. By Application 16.2.2.3. By End-User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product 16.3.2.2. By Application 16.3.2.3. By End-User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product 16.4.2.2. By Application 16.4.2.3. By End-User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product 16.5.2.2. By Application 16.5.2.3. By End-User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product 16.6.2.2. By Application 16.6.2.3. By End-User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product 16.7.2.2. By Application 16.7.2.3. By End-User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product 16.8.2.2. By Application 16.8.2.3. By End-User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product 16.9.2.2. By Application 16.9.2.3. By End-User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product 16.10.2.2. By Application 16.10.2.3. By End-User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product 16.11.2.2. By Application 16.11.2.3. By End-User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product 16.12.2.2. By Application 16.12.2.3. By End-User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product 16.13.2.2. By Application 16.13.2.3. By End-User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product 16.14.2.2. By Application 16.14.2.3. By End-User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product 16.15.2.2. By Application 16.15.2.3. By End-User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product 16.16.2.2. By Application 16.16.2.3. By End-User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product 16.17.2.2. By Application 16.17.2.3. By End-User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product 16.18.2.2. By Application 16.18.2.3. By End-User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product 16.19.2.2. By Application 16.19.2.3. By End-User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product 16.20.2.2. By Application 16.20.2.3. By End-User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product 16.21.2.2. By Application 16.21.2.3. By End-User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product 16.22.2.2. By Application 16.22.2.3. By End-User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product 16.23.2.2. By Application 16.23.2.3. By End-User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Application 17.3.4. By End-User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Siemens AG 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. GE Healthcare 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Philips Healthcare 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Digirad Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Surgiceye GmbH. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Koninklijke Philips N.V. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Toshiba Medical Systems Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Neusoft Medical Systems Co., Ltd. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Mediso Medical Imaging Systems Co., Ltd 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. CMR Naviscan Corporation 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Nuclear Imaging Equipment Market
